Professional Documents
Culture Documents
NYOTO WIDYO A
Subbagian Hematologi-Onkologi Medik,
Bagian Ilmu Penyakit Dalam,
RSPAD GATOT SOEBROTO,
Jakarta
Hematopoiesis
IL-6 GM-CSF
BFU E
CFU L
IL-1 IL-2
IL-2
CFC Mix
IL-6
Pro B
MGDF, TPO
IL-2
IL-4
GM-CSF
CFC E
Erithroblast
Myeloblast
CFU Meg
CFC TL
Pro Megacaryoblast
IL-4
CFC BL
IL-2
T Lymphoblast B
Lymphoplasmacytoid
Plasma cell
IL-6
IL-6
IL-6
GM-CSF
MGDF
IL-2
Visible Hb
IL-6
LAK NK
IL-2
IL-4
Proerythroblast
Promyelocyte
Mega
Normoblast :
B Centroblast
karyoblast T Immunoblast
Basophylic
Myelocyte
Polychromatophylic
B Immunoblast
Metamyelocyte Megakaryocyte
Orthochromatophylic
IL-12
IL-4
IL-11
T cell
Reticulocyte
Band
Centrocyte
Thrombocyte
Erythrocyte
Segmen
EPO
Maturasi
GM-CSF IL-3
CFU GM
EPO
B cell
Erythropoiesis
Time to circulation of
red blood cells from
Stem cell in BM have
app.120 days
2.3 million red blood
cells produced every
second in human bone
marrow
138 million every
minute
18.4 billion between
now and lunch-time!
Main regulator is
Erythropoiesis: Growth
Factors
___________SCF____________
___________ IL-11___________
______________ IL-3___________________________
______G-CSF _____ _______ GM-CSF_______
_______IL-6_______ _______IL-4_______
_________EPO_________
_______IL-9_______
Quiescent
stem cell
Activated
stem cell
BFU-E
CFU-E
Erythrocyte
Mechanism of action of
EPO
Increase in total RNA synthesis
uptake
Increase Heme synthesis
Increase rate of transcription of and -globin gene
Increase Hemoglobin synthesis
In absence of EPO
Decrease synthesis of cytochromes, catalase, peroxidase
Rapid DNA cleavage apoptosis
IRON ABSORPTION
Ferrokinetik
Fe+2
DCyt-b
DMT1
Fe+3
Ferritin
TFR
Fe
Heme
Ferroportin
Hepaestin
Fe-transferin
SI
Hemosiderin
cytochrome
Apoferritin
Apotransferin
Hemoglobi
nNormal:
Foetal:
Dewasa:
Intracellular site
protein (globins)
product
B=babies
A=adult
B A
Fe
Fe
Fe
Heme
Heme
Heme
HbF
HbA2
HbA1
Hemoglobi
involvements normal globin
nGenotype
Hb F
:
Hb A2
Hb A1
:
:
Mengikat oksigen
Fe
Fe
Fe
Heme
Heme
Heme
HbF
HbA2
HbA1
Definisi anemia
Keadaan dimana kadar hemoglobin
< 13 gr%,
Wanita < 12 gr%, dan
Kehamilan 10 gr%.
Grading anemia
Hb
Ringan (mild)
10 mg/dL
Sedang (moderate) 8 <10 mg/dL
Nyata (marked) 6 <8 mg/dL
Berat (severe)
< 6 mg/dL
Digunakan dalam diagnostik laboratorium sebagai research cutof
Tidak dapat digunakan untuk batasan diagnostik klinis
Mekanisme
System/orga
n
Symptom
Penurunan
kapasitas
angkut oksigen
End arteries
Jantung
Respiratory
Neuromuscular
Hearing
Sighting
Pale (vasoconstriction)
Tachycardia, systolic ejection murmur, Forth gallop
Tachypneu, Exertional dyspneu
Faintness, Lack of concentration,
Tinnitus (ischemic)
Scotoma (edema papil)
Perdarahan
Haid
Feses
Hidung
Mulut
Menorhagia, Polymenorrhagia
Melena, hematoschezia
Epistaksis
Gusi berdarah
Atropi-Nekrosis
Mucosa
Tongue
Pharinx
Neuritis
Kaki/Tangan
Hemolisis
Intravascular
Urin
Hemolisis
Extravascular
Urin
Limpa
Hepato-splenomegali
Extramedullar
Inti Makrositik
Sitoplasma Mikrositik hipokrom
Defisiensi eritropoietin
Defisiensi ACTH
Defisiensi protein
1)
2)
3)
Defect extracorpuscular
III. Perdarahan
b.
Inti (Makrositik):
1)
Normal megaloblastik:
2)
Abnormal megaloblastik:
b.
e.
Defisiensi eritropoietin
d.
c.
Renal disease
Defisiensi ACTH
Defisiensi protein
Antibody erythropoietin
Antibody erythropoietin receptors
Penghancuran SDM
a. Defect corpuscular:
1. Defect membrane
a.
Congenital
a.
b.
c.
b.
Didapat
a.
b.
Stomacytosis
Hypophosphatemia
b.
Autosom recessive
X linked
Thalasemia
Hemoglobinopati
Penghancuran SDM
(lanjutan)
b. Defect extracorpuscular
1.
2.
3.
4.
Hypersplenism
Immune hemolysis (AIHA, SLE, APS, PCH)
Complement sensitivated (PNH)
Mekanik: Penurunan shear rate
a.
b.
5.
Toksin:
a.
b.
c.
6.
Sistemik: CHF
Partial luas: TTP, KID, Vasculitis, Hemangioma, dll.
Obat-obatan: Sulfonamida, dll.
Metabolit: Uremia (HUS), Cyclosporin, dll.
Zat kimia: Bahan pewarna (Anilin), dll.
Infeksi:
a.
b.
Penggolongan menurut
Morfologi volumetrik
Mikrositik
hipokrom
MCV < 80 fL
MCH 27 pg
MCHC < 30 g/dL
Normositik
normokrom Makrositik
80 100 fL > 100 fL
> 27 pg
> 27 pg
30 g/dL
30 g/dL
MCV= (Ht/Eritosit)x10 fL
MCH=(Hb/Eritrosit)x10 pg
MCHC=(Hb/Ht)x100 g/dL
Anemia mikrositik
hipokrom
Diagnostik:
Rerata volume eritrosit (VER) < 80 fL dan
Rerata konsentrasi hemoglobin eritrosit (KHER) < 30
g/dL atau
Rerata konsentrasi hemoglobin (HER) 27 pg/dL.
Penyebab:
hemoglobinopati,
Retikulosit
Rasio retikulosit =Hitung Retikulosit x 1000
Hitung Eritrosit
Indeks/koreksi retikulosit (Normal: 5-15 .);
Ht
Pria
: 42 x Rasio retikulosit
Ht
Wanita
: 39 x Rasio retikulosit
Hb
18
17
16
15
14
13
12
11
10
Ht
54
51
48
45
42
39
36
33
30
Rasio Retikulosit ()
Pria
Wanita
4.0
3.6
4.2
3.9
11.8
11.0
4.4
4.1
12.5
11.7
4.7
4.4
13.2
12.4
5.0
4.7
14.1
13.1
5.4
5.0
15.0
14.0
5.8
5.4
16.1
15.0
6.3
5.8
17.3
16.2
6.8
6.4
18.8
17.5
20.5
19.1
Normal/Tinggi
Elektroforesis hemoglobin
Normal
Defisiensi Fe
Dalam terapi Fe ?
BMP
Abnormal
Hemoglobinopati
Pasokan, Absorpsi ?
Hemolitik ?
Gangguan metabolisme
Fe
Mielodisplasia (MDS)
Anemia of Chronic Diseases (ACD)
Thalasemia
Normal limit:
SI
50 -150 g/dL
IBC
250-410 g/dL
Serum feritin 20-200 ng/mL,
excess >400 ng/mL
Defisiensi Besi
Defisiensi besi ringan
IST
SI
* 100%
TIBC
Iron Sucrose
Anemia makrositer
Diagnostik: MCV > 100 fL
Penyebab:
Inefective
Defisiensi Folat
Analisis gizi
Baik
Defisiensi B12
Perdarahan/Hemolisis ?
Normal
Schilling test
TIDAK
YA
BMP
Malabsorpsi
Def. IntrinsikMalabsorpsi
Inapropriate diet
Cincin sideroblastik
Hipoplastik
mieloptisis
Kongenital/Obat
Abnormal
Hambatan
Produksi/Pematangan
BMP
Normal
Anemia hemolitik/def.Fe
dalam terapi ?
Periksa ACTH
Kehilangan/Penghancuran Berlebihan
Periksa: Bilirubin indirek, LDH
Normal
Tinggi
Perdarahan
?
Anemia Hemolitik
Tidak
Ya
Periksa urin
Infiltrasi Keganasan
Hipoplasia
SSTL
Cincin sideroblastik ?
Negatif
Tes coombs, C3/C4
Anti dsDNA
Positif
AIHA Primer or Secunder
Negatif
Defect Intra corpuscular
Positif Hb/
hemosiderin
Hemolisis
Hemolisis
Ekstravaskular Intravaskular
Defect Extra corpuscular
Mekanik, Toksin, Infeksi
Anemia normositik
normokrom
Diagnostik:
MCV
80-100 fL dan
MCH > 27 pg atau MCHC 30 g/dL
Penyebab:
Kegagalan
distribusi.
Hambatan produksi,
Kehilangan/Destruksi berlebihan.
sekunder:
Defect corpuscular
Defisiensi enzim eritrosit (G6PD, dll)
Pemeriksaan yang diperlukan:
Hemoglobinopati
Thalasemia, Sickel cels anemia, dll
Pemeriksaan yang diperlukan:
Herediter sferositosis
Pemeriksaan yang diperlukan:
Defect corpuscular
PNH
Pemeriksaan yang diperlukan:
Porfiria
Pemeriksaan yang diperlukan:
Pemeriksaan Porfirin,
Pemeriksaa Fosfatidil-inositol.
Mekanik:
Toksik:
Metabolit:
Thalasemia
Thalasemia : kegagalan produksi globin rantai
Thalasemia : Present Hb H or Barts
Single gene
Double gene
Genotype Hb Barts :
Triple gene
Genotype Hb H
:
Thalasemia : kegagalan produksi globin rantai
Heterozygot: defect gene (allele) single haploid
Homozygotes: defect gene (allele) diploid
Thalasemia : defect gene dan
Heterozygot: defect gene and(allele) single haploid
Homozygotes: defect gene and(allele) diploid
q 11
q 16
Hb F :
Hb A2 :
Hb A1 :
Genotype globins
Homozygote
Heterozygote
Homozygote
Heterozygote
Intracellular
site protein
(globins)
product
B=babies
A=adult
B A
Globin abnormal
Abnormal hemoglobin:
Thalasemia
Insufficient of normal
globin
Hb Barts ()
Hb H ().
Hemoglobinopati
Changes amino acid in
normal globin
Hb
Hb
Hb
Hb
Hb
Hb
C,
D,
E,
G,
S, sickle cell
variant
Thalasemia
Delesi
Anemia
Heterozygote
Ringan
Homozygote
SedangBerat
>
85%
> 3.5%
Heterozygote
Ringan
> 5%
< 1%
Homozygote
SedangBerat
100
%
Absent
single gene
Non
double gene
Ringan
<
< 2.5%
0.5%
<
< 2.5% Presen
0.5%
t
Mix
<0.5
Sedang
>3%
Presen
Clinical form
Thalasemia
Silent carrier (no hematologic or clinical symptom)
Trait
HbH disease
Unusual form
Thalasemia MDS
Thalasemia and Mental retardation syndromes
Thalasemia Associated with Structural Variants
Clinical form
Thalasemia
Mayor (Homo/Heterozygote) :
Transfusion dependent anemia
Intermedia (Homo/Heterozygote) :
Transfusion Independent anemia
Minor (Heterozygote) :
Asymptomatic
Minima (Heterozygote) :
Silent carrier (no hematologic or clinical symptom)
Single genes
Double genes
Triple genes
Homozygotes
+++ +++
++ ++
+
+
+
++
+++
++
+
++ ++
+++ +++
Erythroblastosis foetalis
Hemolytic anemia of the foetus
Frequently caused by transplacental transmission of maternal
antibody
Immunogenisitas
Eritrosit
ABOEritrosit
& Rhesus
Serum
Reagen
Reagen
Ag
Blood
Type
Ab
AgA
AgB
None
A&B
A &B
None
AB
AbA
AbB
Ab-Rho
ABO
Ag-Rho
Rhesus
Rho
None
Rh+
None
Rho+
Rh-
B
A
A and B
Rho(C,D,E)
None
None
None
Kell (K)
Rho(C,D,E
Dufy (Fy)
hr (c,e)
erythrocyte
)
None
None
None
?
?
B
A
O
RhRh+
KFyhrc,e -
-/+
Janin
AB
-/
+
-/+
AB
Rh+
Ibu O A
AB
AB
Rh+
Rh-
Rh+
Rh-
Rh
+
-/+
Rh-
Rh- Donor
-/+
Antibodi:
Antigen: Donor
Resepien
Resepien
Antibodi: Ibu
Antibodi: Janin
Janin
Ibu
Gene function
(Suppressor genes)
Protein/Amino acid
(Proto-oncogenes)
Control
Protein/Amino acid
Inducers
Hyperplasia:
Control proliferation
Inducers proliferation
Hypoplasia:
Control proliferation
Inducers proliferation
Cells Proliferation
Cells Diferentiation
Kanker
Sel kanker
sel tumor
Muasal
Proto-onkogen: gen yang akan mengalami
penambahan atau relokasi material genetik (amplifikasi).
Gen supresor tumor atau gen anti tumor: gen yang
akan mengalami kehilangan material genetiknya (LOH).
Fungsi
Proto-onkogen changes
Gen supresor tumor
Onkogen
Leukemia
Generalized neoplastic disorders of the
Minimal diferentiation/maturation
Chronic
Normal diferentiation/maturation
ME ratio > 1
PAS
Negative
Negative
Positive
Positive
M6/M7
M0/ALL
AP-L
SBB/POX
Negative
Positive
B cell
M0
ALL
NSE
+
T cell
>3%
30%
M3
100
%
80%
90%
Subclassification of ALL
Cell size
chromatin
nucleoli
cytoplasm
L1
Homogenous
Small
Homogenous
Rare
Minimal
No granules
L2
Heterogeneou
s
Larger
Heterogeneou
s
More present
Often moderately
Some deep
basophilic
Homogenous
Larger
Finely
homogenous
stippled
Moderately
Prominent one
Deep basophilic
or more
and prominent
vesicular
vacuolation
L3
Terima kasih
Immunophenotype
Positive
Negative
M0
M1 HLA-DR, CD13, CD15, CD33, CD34,
CD65
M2 HLA-DR, CD13, CD14, CD33, CD36
M3 CD13, CD33, CD65
CD15, HLADR
CD33
L2
CD33